Skip to main content
Braster S.A. logo

Braster S.A. — Investor Relations & Filings

Ticker · BRA ISIN · PLBRSTR00014 LEI · 259400GV3T3LOS094487 WAR Manufacturing
Filings indexed 1,512 across all filing types
Latest filing 2022-06-17 Major Shareholding Noti…
Country PL Poland
Listing WAR BRA

About Braster S.A.

https://www.braster.eu/en

Braster S.A. is a medical technology company specializing in the development, production, and marketing of diagnostic devices for breast health. Its core product is the Braster System, a medical device designed for regular, in-home breast examination. The system utilizes a proprietary contact thermography method with liquid crystal technology to monitor temperature distribution within the breasts. It functions by detecting and recording areas of elevated temperature, which may indicate pathological changes. The Braster device is intended as a non-invasive, complementary screening tool to be used by women as an adjunct to standard diagnostic procedures such as mammography and ultrasound, promoting systematic breast health monitoring.

Recent filings

Filing Released Lang Actions
Informacja o transakcji dokonanej przez osobę pełniącą obowiązki zarządcze przekazana w trybie art. 19 Rozporządzenia MAR. - Content (PL)
Major Shareholding Notification Classification · 99% confidence The document text is very short (346 characters) and written in Polish. It states that the Management Board of BRASTER S.A. received a notification from the CEO (Dariusz Karolak) regarding transactions involving the acquisition of company shares on specific dates (June 10, 13, and 14, 2022). The text explicitly mentions that the content of the notification is provided in the attachment ('Treść ww. zawiadomień Spółka przekazuje w załączeniu'). This structure—a brief announcement stating that insider transaction details are attached—strongly suggests a notification of insider dealing rather than the full regulatory filing itself. The category 'Director's Dealing' (DIRS) covers reports of personal share transactions by directors and executives. Since the core content is the transaction notification, DIRS is the most appropriate classification, even though the announcement itself might technically fall under RNS if it were purely a generic regulatory notice. Given the specific content about executive share acquisition, DIRS is superior to RNS.
2022-06-17 Polish
Rejestracja akcji zwykłych na okaziciela serii L Spółki w KDPW - Content (PL)
Share Issue/Capital Change Classification · 98% confidence The document discusses the registration of new shares (Series L) with the National Securities Depository (KDPW) resulting from a bond conversion, leading to an increase in the company's share capital. This action directly relates to changes in the company's capital structure and the issuance of new shares. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP) or potentially 'Share Issue/Capital Change' (SHA). Since the core event is the finalization of a capital increase via share issuance following a debt conversion, SHA is the most precise fit, as it covers capital structure changes and new share issues. The document details the exact number of shares, the resulting total capital, and the breakdown of all share series.
2022-06-10 Polish
Rozszerzenie współpracy z Genworks Health Private Limited z siedzibą w Indiach - Content (PL)
Regulatory Filings Classification · 100% confidence The document is a formal announcement (Raport Bieżący) detailing a significant expansion of a cooperation agreement (Memorandum of Understanding) with an Indian distributor, involving new territories (Asia, Middle East, Africa), financial commitments ($0.9M USD in advances/investment), and strategic plans (Joint Venture, telemedicine center). This concerns business strategy, financing arrangements (advances/investment), and expansion of commercial rights. It is not a full annual report (10-K), an earnings release (ER), or a standard dividend notice (DIV). Since it details significant changes in commercial agreements, financing structure (potential investment), and expansion of operations, it best fits the category of Capital/Financing Update (CAP) due to the explicit mention of investment in shares/financial instruments, or potentially Regulatory Filings (RNS) as a general corporate announcement. Given the focus on securing future funding/investment via advances and potential equity participation, CAP is a strong candidate. However, as it is a detailed update on a strategic business agreement expansion, and not purely a financing announcement, RNS (Regulatory Filings - general fallback for significant corporate actions not covered elsewhere) is often used for such broad strategic partnership updates, especially when they involve future capital commitments. Since the text heavily discusses the expansion of commercial rights and strategic partnership terms, and includes potential investment, I will classify it as a general Regulatory Filing (RNS) as it is a broad corporate action announcement, although CAP is closely related due to the investment clause. Given the context of Polish regulatory filings (Raport Bieżący), RNS serves as the most appropriate general category for significant, non-standard announcements.
2022-06-08 Polish
Sprawozdanie_z_badania_Braster_S.A._w_restrukturyzacji.xhtml.xades
Audit Report / Information Classification · 95% confidence The provided document text consists almost entirely of XML digital signature blocks (Signature, SignedInfo, KeyInfo, etc.). Within the signature references, there is a key piece of information: the URI points to a file named "Sprawozdanie z badania Braster S.A. w restrukturyzacji.xhtml". The Polish phrase "Sprawozdanie z badania" translates to "Audit Report" or "Report of examination". Furthermore, the document length is 5802 characters, which is relatively short for a full financial report (like a 10-K or IR), and the content is purely metadata/signature, suggesting this is likely an attachment or a cover page/signature block accompanying the main report. Given the explicit mention of an 'Audit Report' ('Sprawozdanie z badania'), the most appropriate classification is Audit Report / Information (AR). Since the text itself is just the signature block, it could potentially be RPA, but the content strongly identifies the nature of the attached/signed document as an Audit Report. FY 2021
2022-06-06 Polish
Sprawozdanie_z_badania_Braster_S.A._w_restrukturyzacji.xhtml
Audit Report / Information Classification · 100% confidence The document text is explicitly titled "SPRAWOZDANIE Z BADANIA sprawozdania finansowego za 2021 rok" (Report on the audit of the financial statement for 2021) and contains the full text of the "SPRAWOZDANIE NIEZALEŻNEGO BIEGŁEGO REWIDENTA Z BADANIA ROCZNEGO SPRAWOZDANIA FINANSOWEGO" (Independent Auditor's Report on the Audit of the Annual Financial Statement). It details the audit opinion, the basis for the opinion, key audit matters, and the responsibilities of management and the auditor, referencing Polish accounting laws and International Standards on Auditing (KSB). This content perfectly matches the definition of an Audit Report/Information (AR), which covers standalone audit reports and applied accounting principles, distinguishing it from a full Annual Report (10-K) or an Earnings Release (ER). FY 2021
2022-06-06 Polish
Oswiadczenie_RN_ws._komitetu_Audytu__.xhtml
Governance Information Classification · 98% confidence The document is a formal declaration ('Oświadczenie') from the Supervisory Board ('Rada Nadzorcza') of BRASTER S.A. in restructuring, dated May 20, 2022. It specifically addresses the Audit Committee ('Komitet Audytu') and confirms compliance with regulations regarding its establishment, composition, functioning, and the fulfillment of its duties, referencing a specific Polish Ministry of Finance regulation. This content directly relates to the internal rules, board structure, and governance practices of the company, making it a Governance Information document.
2022-06-06 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.